Invoiced vs. net sales of top-selling U.S. drugs 2019
In 2019, Humira made 14.9 billion U.S. dollars in net sales despite making 21.4 billion U.S. dollars on nondiscounted invoiced sales in the United States. This statistic illustrates the gap between invoiced and net sales for top-selling drugs in the United States in 2019, by drug. In general, drugs which have more competitors usually offer higher rebates than drugs with few or no competitors.
